Citius Oncology, Inc. ( CTOR) - Stock Earnings
CTOR Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -5.5 million USD | 3.9 million USD |
| 2026Q1 | -26.6 million USD | 1.7 million USD |
| 2026Q2 | -8.9 million USD | 1.5 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
CTOR Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -12.7 million USD | — USD |
| 2024 | -21.1 million USD | — USD |
| 2025 | -24.8 million USD | — USD |
| 2026 Est. | — | — |
CTOR
Price: $0.57
52 week price:
Earnings Per Share: -0.48 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 55.2 million